Who owns TELIX PHARMACEUTICAL LTD SPONSORED?
- Ticker: TLX
- CUSIP Number: 87961m105
Tip: Access positions for across all investors
Analyze quarterly positions in Telix Pharmaceutical Ltd Sponsored with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Telix Pharmaceutical Ltd Sponsored stock
Who bought or sold TELIX PHARMACEUTICAL LTD SPONSORED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Portland Investment Counsel | 266k | $2.1M | 108% | Dec 2025 |
|
| Lazard Asset Management | 251k | $1.9M | 119% | Dec 2025 |
|
| Private Advisor | 174k | $1.7M | 276% | Mar 2026 |
|
| Raiffeisen Bank International | 130k | $1.2M | 100% | Mar 2026 |
|
| FMR | 124k | $926k | 4% | Dec 2025 |
|
| Marshall Wace | 47k | $350k | -4% | Dec 2025 |
|
| Jane Street | 40k | $300k | -45% | Dec 2025 |
|
| Quadrature Capital | 37k | $276k | 100% | Dec 2025 |
|
| Mariner Wealth Advisors | 37k | $274k | 100% | Dec 2025 |
|
| Vident Advisory | 27k | $204k | 100% | Dec 2025 |
|
| IHT Wealth Management | 25k | $189k | -4% | Dec 2025 |
|
| Citadel Advisors | 23k | $172k | 100% | Dec 2025 |
|
| Millennium Management | 20k | $148k | -90% | Dec 2025 |
|
| Point72 Asset Management | 18k | $138k | 100% | Dec 2025 |
|
| JustInvest | 18k | $136k | -1% | Dec 2025 |
|
| Old Mission Capital | 15k | $111k | 100% | Dec 2025 |
|
| XTX Topco | 12k | $89k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 11k | $81k | 318% | Dec 2025 |
|
| UBS Group | 2.0k | $15k | -65% | Dec 2025 |
|
| Goss Wealth Management | 1.9k | $14k | -20% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.5k | $11k | 100% | Dec 2025 |
|
| SRS Capital Advisors | 1.1k | $8.1k | 5% | Dec 2025 |
|
| EverSource Wealth Advisors | 898.00 | $6.6k | 618% | Dec 2025 |
|
| Ronald Blue Trust | 742.00 | $7.1k | -76% | Mar 2026 |
|
| Aspect Partners | 380.00 | $3.6k | 8% | Mar 2026 |
|
| Advisor Group Holdings | 314.00 | $2.4k | -7% | Dec 2025 |
|
| CVA Family Office | 127.00 | $1.2k | 100% | Mar 2026 |
|
| BlackRock | 88.00 | $658.996800 | 100% | Dec 2025 |
|
| Smartleaf Asset Management | 72.00 | $558.000000 | 100% | Dec 2025 |
|
| Bell Investment Advisors | 70.00 | $669.998000 | 100% | Mar 2026 |
|
| NISA Investment Advisors | 65.00 | $621.998000 | 100% | Mar 2026 |
|
| MV Capital Management | 61.00 | $584.001800 | 455% | Mar 2026 |
|
| Assetmark | 45.00 | $337.000500 | 10% | Dec 2025 |
|
| Transamerica Financial Advisors | 25.00 | $187.000000 | 0% | Dec 2025 |
|
| Parallel Advisors | 12.00 | $93.000000 | 100% | Dec 2025 |
|
| Farther Finance Advisors | 9.00 | $82.999800 | 0% | Mar 2026 |
|
| SageView Advisory Group | 2.00 | $15.000000 | 100% | Dec 2025 |
|
Who sold out of Telix Pharmaceutical Ltd Sponsored?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hrt Financial | Sep 2025 | 12k | $111k |
| State of Wyoming | Sep 2025 | 1.3k | $12k |
| Independence Bank of Kentucky | Dec 2025 | 66.00 | $493.996800 |
| Larson Financial Group | Sep 2025 | 53.00 | $506.998000 |
| Principal Securities | Sep 2025 | 21.00 | $200.999400 |
| True Wealth Design | Dec 2025 | 3.00 | $23.000100 |